PL366780A1 - Sulfonamidy 2-(podstawionego-amino) benzoksazolu jako inhibitory proteazy HIV o szerokim zakresie działania - Google Patents

Sulfonamidy 2-(podstawionego-amino) benzoksazolu jako inhibitory proteazy HIV o szerokim zakresie działania

Info

Publication number: PL366780A1
Authority: PL; Poland
Prior art keywords: broadspectrum; amino; protease inhibitors; hiv protease; benzoxazole sulfonamide
Prior art date: 2001-05-11

Application number

PL02366780A

Other languages

English (en)

Other versions

PL209029B1 (pl

Inventor

Dominique Louis Nestor Ghislain Surleraux

Sandrine Marie Helene Vendeville

Wim Gaston Verschueren

Bethune Marie-Pierre T.M.M.G. De

Kock Herman Augustinus De

Abdellah Tahri

Original Assignee

Tibotec Pharmaceuticals Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-11

Filing date

2002-05-10

Publication date

2005-02-07

2002-05-10 Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.

2005-02-07 Publication of PL366780A1 publication Critical patent/PL366780A1/pl

2011-07-29 Publication of PL209029B1 publication Critical patent/PL209029B1/pl

Links

SDCCPSGJFZFNPB-UHFFFAOYSA-N 2-amino-3h-1,3-benzoxazole-2-sulfonamide Chemical compound C1=CC=C2OC(N)(S(N)(=O)=O)NC2=C1 SDCCPSGJFZFNPB-UHFFFAOYSA-N 0.000 title 1
239000004030 hiv protease inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

PL366780A 2001-05-11 2002-05-10 Pochodne 2-aminobenzoksazolo-sulfonamidów jako inhibitory proteazy HIV, oraz kompozycje zawierające te związki PL209029B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01201732		2001-05-11

Publications (2)

Publication Number	Publication Date
PL366780A1 true PL366780A1 (pl)	2005-02-07
PL209029B1 PL209029B1 (pl)	2011-07-29

Family

ID=8180286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL366780A PL209029B1 (pl)	2001-05-11	2002-05-10	Pochodne 2-aminobenzoksazolo-sulfonamidów jako inhibitory proteazy HIV, oraz kompozycje zawierające te związki

Country Status (31)

Country	Link
US (2)	US7622490B2 (pl)
EP (1)	EP1387842B1 (pl)
JP (1)	JP4467889B2 (pl)
KR (1)	KR100878853B1 (pl)
CN (1)	CN100549007C (pl)
AP (1)	AP1652A (pl)
AR (1)	AR035970A1 (pl)
AT (1)	ATE429431T1 (pl)
AU (1)	AU2002310818B2 (pl)
BG (1)	BG66350B1 (pl)
BR (1)	BR0209594A (pl)
CA (1)	CA2444895C (pl)
CY (1)	CY1109247T1 (pl)
CZ (1)	CZ304524B6 (pl)
DE (1)	DE60232067D1 (pl)
DK (1)	DK1387842T3 (pl)
EA (1)	EA009590B1 (pl)
EE (1)	EE05307B1 (pl)
ES (1)	ES2325809T3 (pl)
HR (1)	HRP20031026B1 (pl)
HU (1)	HUP0400438A3 (pl)
IL (1)	IL158093A0 (pl)
MX (1)	MXPA03010258A (pl)
NO (1)	NO326883B1 (pl)
NZ (1)	NZ529250A (pl)
OA (1)	OA13134A (pl)
PL (1)	PL209029B1 (pl)
PT (1)	PT1387842E (pl)
SK (1)	SK287952B6 (pl)
WO (1)	WO2002092595A1 (pl)
ZA (1)	ZA200307799B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
EP1175205B1 (en)	1999-11-12	2006-06-14	Abbott Laboratories	Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7109230B2 (en)	2002-01-07	2006-09-19	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
US7157489B2 (en)	2002-03-12	2007-01-02	The Board Of Trustees Of The University Of Illinois	HIV protease inhibitors
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
WO2005030739A1 (en) *	2003-09-30	2005-04-07	Tibotec Pharmaceuticals Ltd.	Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
US8193227B2 (en)	2003-12-11	2012-06-05	Abbott Laboratories	HIV protease inhibiting compounds
US20050131042A1 (en) *	2003-12-11	2005-06-16	Flentge Charles A.	HIV protease inhibiting compounds
JP4818124B2 (ja)	2003-12-23	2011-11-16	テイボテク・フアーマシユーチカルズ・リミテツド	（３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法
KR101192859B1 (ko)	2003-12-23	2012-10-19	얀센 알 앤드 디 아일랜드	（3ｒ,3ａｓ,6ａｒ）-헥사하이드로푸로〔2,3-ｂ〕푸란-3-일（1ｓ,2ｒ）-3-〔〔（4-아미노페닐）설포닐〕（이소부틸）아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법
AU2005244121B2 (en) *	2004-05-07	2012-01-19	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es)	2005-02-25	2009-12-28	Tibotec Pharmaceuticals	Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) *	2005-04-15	2007-05-23	Tibotec Pharm Ltd	5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US20120220520A1 (en) *	2006-10-17	2012-08-30	Van T Klooster Gerben Albert Eleutherius	Bioavailable combinations for hcv treatment
WO2014194519A1 (en)	2013-06-07	2014-12-11	Merck Sharp & Dohme Corp.	Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8204879D0 (sv)	1982-08-26	1982-08-26	Haessle Ab	Novel chemical intermediates
DE69121436T2 (de)	1990-03-09	1997-01-09	Milliken Res Corp	Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
CA2142998C (en) *	1992-08-25	2008-01-29	Michael L. Vazquez	N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
PH30929A (en)	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
ES2127938T3 (es)	1993-08-24	1999-05-01	Searle & Co	Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
ES2166786T3 (es)	1993-10-01	2002-05-01	Astrazeneca Ab	Procedimiento i.
DE69637380T2 (de)	1995-01-20	2009-09-17	G.D. Searle Llc, Chicago	Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
US5756533A (en) *	1995-03-10	1998-05-26	G.D. Searle & Co.	Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
CN1149223C (zh)	1995-03-10	2004-05-12	G·D·瑟尔公司	杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
US6150556A (en) *	1995-03-10	2000-11-21	G. D. Dearle & Co.	Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) *	1995-03-10	1998-01-06	G.D. Searle & Co.	Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5753660A (en) *	1995-11-15	1998-05-19	G. D. Searle & Co.	Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6509038B2 (en)	1996-05-20	2003-01-21	Janssen Pharmaceutica N.V.	Antifungal compositions with improved bioavailability
CZ295502B6 (cs)	1997-03-26	2005-08-17	Janssen Pharmaceutica N. V.	Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
GB9717849D0 (en)	1997-08-23	1997-10-29	Seal Sands Chemicals Limited	Preparation of pyridene derivatives
EP1042280A2 (en)	1997-12-24	2000-10-11	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
AU2010299A (en)	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs os aspartyl protease inhibitors
US6436989B1 (en)	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
AU2012199A (en)	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
AU4828199A (en)	1998-06-23	2000-01-10	Board Of Trustees Of The University Of Illinois, The	Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt)	1998-06-23	2016-10-19	The Board Of Trustees Of The Univ Of Illionis	Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
EP1397367A2 (en) *	2001-04-09	2004-03-17	Tibotec Pharmaceuticals Ltd.	Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors

2002
- 2002-05-10 US US10/474,485 patent/US7622490B2/en not_active Expired - Fee Related
- 2002-05-10 EE EEP200300547A patent/EE05307B1/xx not_active IP Right Cessation
- 2002-05-10 CA CA2444895A patent/CA2444895C/en not_active Expired - Fee Related
- 2002-05-10 CZ CZ2003-3290A patent/CZ304524B6/cs not_active IP Right Cessation
- 2002-05-10 SK SK1490-2003A patent/SK287952B6/sk not_active IP Right Cessation
- 2002-05-10 EP EP02735354A patent/EP1387842B1/en not_active Expired - Lifetime
- 2002-05-10 AU AU2002310818A patent/AU2002310818B2/en not_active Ceased
- 2002-05-10 JP JP2002589479A patent/JP4467889B2/ja not_active Expired - Fee Related
- 2002-05-10 DE DE60232067T patent/DE60232067D1/de not_active Expired - Lifetime
- 2002-05-10 AT AT02735354T patent/ATE429431T1/de active
- 2002-05-10 ES ES02735354T patent/ES2325809T3/es not_active Expired - Lifetime
- 2002-05-10 NZ NZ529250A patent/NZ529250A/en not_active IP Right Cessation
- 2002-05-10 HU HU0400438A patent/HUP0400438A3/hu not_active IP Right Cessation
- 2002-05-10 HR HRP20031026AA patent/HRP20031026B1/xx not_active IP Right Cessation
- 2002-05-10 PL PL366780A patent/PL209029B1/pl unknown
- 2002-05-10 BR BR0209594-7A patent/BR0209594A/pt not_active IP Right Cessation
- 2002-05-10 PT PT02735354T patent/PT1387842E/pt unknown
- 2002-05-10 EA EA200301234A patent/EA009590B1/ru not_active IP Right Cessation
- 2002-05-10 KR KR1020037013145A patent/KR100878853B1/ko not_active Expired - Fee Related
- 2002-05-10 OA OA1200300277A patent/OA13134A/en unknown
- 2002-05-10 CN CNB028097416A patent/CN100549007C/zh not_active Expired - Fee Related
- 2002-05-10 DK DK02735354T patent/DK1387842T3/da active
- 2002-05-10 AP APAP/P/2003/002904A patent/AP1652A/en active
- 2002-05-10 MX MXPA03010258A patent/MXPA03010258A/es active IP Right Grant
- 2002-05-10 IL IL15809302A patent/IL158093A0/xx not_active IP Right Cessation
- 2002-05-10 WO PCT/EP2002/005212 patent/WO2002092595A1/en not_active Ceased
- 2002-05-10 AR ARP020101722A patent/AR035970A1/es active IP Right Grant
2003
- 2003-10-06 ZA ZA2003/07799A patent/ZA200307799B/en unknown
- 2003-11-03 BG BG108309A patent/BG66350B1/bg unknown
- 2003-11-10 NO NO20034988A patent/NO326883B1/no not_active IP Right Cessation
2009
- 2009-07-21 CY CY20091100774T patent/CY1109247T1/el unknown
- 2009-10-07 US US12/575,216 patent/US7863306B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BG66350B1 (bg)	2013-08-30
CN1507446A (zh)	2004-06-23
IL158093A0 (en)	2004-03-28
EA200301234A1 (ru)	2004-04-29
US20040106661A1 (en)	2004-06-03
ES2325809T3 (es)	2009-09-18
HRP20031026A2 (en)	2005-10-31
CZ304524B6 (cs)	2014-06-18
MXPA03010258A (es)	2005-03-07
CN100549007C (zh)	2009-10-14
AR035970A1 (es)	2004-07-28
EE05307B1 (et)	2010-06-15
EA009590B1 (ru)	2008-02-28
US7863306B2 (en)	2011-01-04
DK1387842T3 (da)	2009-08-10
JP4467889B2 (ja)	2010-05-26
OA13134A (en)	2006-12-13
HUP0400438A2 (hu)	2004-08-30
AP1652A (en)	2006-08-11
EE200300547A (et)	2004-02-16
KR100878853B1 (ko)	2009-01-15
NO20034988D0 (no)	2003-11-10
PT1387842E (pt)	2009-07-20
NZ529250A (en)	2005-05-27
CA2444895A1 (en)	2002-11-21
CA2444895C (en)	2011-02-15
CY1109247T1 (el)	2014-07-02
DE60232067D1 (de)	2009-06-04
WO2002092595A1 (en)	2002-11-21
US20100029632A1 (en)	2010-02-04
ZA200307799B (en)	2005-03-30
HRP20031026B1 (hr)	2012-07-31
EP1387842A1 (en)	2004-02-11
NO326883B1 (no)	2009-03-09
BR0209594A (pt)	2004-03-30
JP2004534757A (ja)	2004-11-18
SK14902003A3 (sk)	2004-07-07
AP2003002904A0 (en)	2003-12-31
KR20040022417A (ko)	2004-03-12
HK1062912A1 (en)	2004-12-03
SK287952B6 (sk)	2012-06-04
HUP0400438A3 (en)	2007-08-28
AU2002310818B2 (en)	2007-12-13
ATE429431T1 (de)	2009-05-15
EP1387842B1 (en)	2009-04-22
US7622490B2 (en)	2009-11-24
BG108309A (bg)	2004-12-30
PL209029B1 (pl)	2011-07-29
CZ20033290A3 (cs)	2004-05-12

Publication	Publication Date	Title
GB0125445D0 (en)	2001-12-12	Protease Inhibitors
AU2002305926A1 (en)	2002-10-08	Cysteine protease inhibitors
AP2003002856A0 (en)	2003-09-30	Broadspectrum 2-(substitutted-amino)-benzothiazolesulphonamide HIV protease inhibitors.
EP1483254A4 (en)	2005-06-08	INHIBITORS OF ANTI-RESISTANCE RETROVIRAL PROTEASE
IL158093A0 (en)	2004-03-28	Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
AP1878A (en)	2008-08-13	Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors.
PL375307A1 (pl)	2005-11-28	Podstawione oksoindolo sulfonamidy jako inhibitory proteazy HIV o szerokim zakresie działania
ZA200410156B (en)	2005-11-30	Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
IL162574A0 (en)	2005-11-20	Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
IL158092A0 (en)	2004-03-28	Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
AU2002360673A8 (en)	2003-06-30	Gp41 inhibitor
EP1401453A4 (en)	2005-04-06	PROTEASE INHIBITORS
HRP20040936A2 (en)	2005-10-31	Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
GB0123467D0 (en)	2001-11-21	Carbocyclic HIV Protease inhibitors
GB0028483D0 (en)	2001-01-10	Hydroxyethylamine HIV protease inhibitors
AU2003287325A8 (en)	2004-06-03	N-cycloalkylglycines as hiv protease inhibitors
ZA200500926B (en)	2006-03-29	Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
AU2002255485A8 (en)	2008-01-10	Hiv/fiv protease inhibitors
IL160626A0 (en)	2004-07-25	Antiviral protease inhibitors
HK1079684A (en)	2006-04-13	Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
AU2002323648A1 (en)	2003-04-01	Sulfonamide compounds as protease inhibitors
AU2002311768A1 (en)	2002-10-08	Aminopyrrolidine sulfonamides as serine protease inhibitors
AU2002341701A1 (en)	2003-04-01	Bis-amino acid sulfonamides as hiv protease inhibitors
HK1079769A (zh)	2006-04-13	取代的羟吲哚磺酰胺类广谱hiv蛋白酶抑制剂
AU2002356595A1 (en)	2003-05-26	Serin protease inhibitors